A Follow-Up Report of an Infant Born to a Mother Receiving Tamoxifen
Tamoxifen, an estrogen receptor antagonist, is contraindicated in pregnant women due to its teratogenic activity. In the present study, we report the case of an infant whose mother received tamoxifen for breast cancer while unaware of the pregnancy. The infant, born at 29 weeks and 6 days of gestati...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2020/2056756 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832553491773521920 |
---|---|
author | Yuki Okada Daisuke Hitaka Takahiro Kido Yu Kanai Kumi Konishi Kosuke Doki Nobuko Katayama Masato Homma Yayoi Miyazono Hidetoshi Takada |
author_facet | Yuki Okada Daisuke Hitaka Takahiro Kido Yu Kanai Kumi Konishi Kosuke Doki Nobuko Katayama Masato Homma Yayoi Miyazono Hidetoshi Takada |
author_sort | Yuki Okada |
collection | DOAJ |
description | Tamoxifen, an estrogen receptor antagonist, is contraindicated in pregnant women due to its teratogenic activity. In the present study, we report the case of an infant whose mother received tamoxifen for breast cancer while unaware of the pregnancy. The infant, born at 29 weeks and 6 days of gestational age with a birth weight of 1664 g, had no congenital anomalies. This case presents detailed information on the development of an infant with placental transfer of tamoxifen. The infant has grown and developed normally throughout a 5-year follow-up period, but long-term vigilance continues. |
format | Article |
id | doaj-art-b05de5d3576c4bab834239e679eaa2a1 |
institution | Kabale University |
issn | 2090-6803 2090-6811 |
language | English |
publishDate | 2020-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Pediatrics |
spelling | doaj-art-b05de5d3576c4bab834239e679eaa2a12025-02-03T05:53:54ZengWileyCase Reports in Pediatrics2090-68032090-68112020-01-01202010.1155/2020/20567562056756A Follow-Up Report of an Infant Born to a Mother Receiving TamoxifenYuki Okada0Daisuke Hitaka1Takahiro Kido2Yu Kanai3Kumi Konishi4Kosuke Doki5Nobuko Katayama6Masato Homma7Yayoi Miyazono8Hidetoshi Takada9Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Ibaraki, JapanDepartment of Pediatrics, University of Tsukuba Hospital, Tsukuba, Ibaraki, JapanDepartment of Pediatrics, University of Tsukuba Hospital, Tsukuba, Ibaraki, JapanDepartment of Pediatrics, University of Tsukuba Hospital, Tsukuba, Ibaraki, JapanDepartment of Pharmacy, University of Tsukuba Hospital, Tsukuba, Ibaraki, JapanDepartment of Pharmacy, University of Tsukuba Hospital, Tsukuba, Ibaraki, JapanDepartment of Child Health, Seinan Medical Center Hospital, Sakai, Ibaraki, JapanDepartment of Pharmacy, University of Tsukuba Hospital, Tsukuba, Ibaraki, JapanDepartment of Pediatrics, University of Tsukuba Hospital, Tsukuba, Ibaraki, JapanDepartment of Pediatrics, University of Tsukuba Hospital, Tsukuba, Ibaraki, JapanTamoxifen, an estrogen receptor antagonist, is contraindicated in pregnant women due to its teratogenic activity. In the present study, we report the case of an infant whose mother received tamoxifen for breast cancer while unaware of the pregnancy. The infant, born at 29 weeks and 6 days of gestational age with a birth weight of 1664 g, had no congenital anomalies. This case presents detailed information on the development of an infant with placental transfer of tamoxifen. The infant has grown and developed normally throughout a 5-year follow-up period, but long-term vigilance continues.http://dx.doi.org/10.1155/2020/2056756 |
spellingShingle | Yuki Okada Daisuke Hitaka Takahiro Kido Yu Kanai Kumi Konishi Kosuke Doki Nobuko Katayama Masato Homma Yayoi Miyazono Hidetoshi Takada A Follow-Up Report of an Infant Born to a Mother Receiving Tamoxifen Case Reports in Pediatrics |
title | A Follow-Up Report of an Infant Born to a Mother Receiving Tamoxifen |
title_full | A Follow-Up Report of an Infant Born to a Mother Receiving Tamoxifen |
title_fullStr | A Follow-Up Report of an Infant Born to a Mother Receiving Tamoxifen |
title_full_unstemmed | A Follow-Up Report of an Infant Born to a Mother Receiving Tamoxifen |
title_short | A Follow-Up Report of an Infant Born to a Mother Receiving Tamoxifen |
title_sort | follow up report of an infant born to a mother receiving tamoxifen |
url | http://dx.doi.org/10.1155/2020/2056756 |
work_keys_str_mv | AT yukiokada afollowupreportofaninfantborntoamotherreceivingtamoxifen AT daisukehitaka afollowupreportofaninfantborntoamotherreceivingtamoxifen AT takahirokido afollowupreportofaninfantborntoamotherreceivingtamoxifen AT yukanai afollowupreportofaninfantborntoamotherreceivingtamoxifen AT kumikonishi afollowupreportofaninfantborntoamotherreceivingtamoxifen AT kosukedoki afollowupreportofaninfantborntoamotherreceivingtamoxifen AT nobukokatayama afollowupreportofaninfantborntoamotherreceivingtamoxifen AT masatohomma afollowupreportofaninfantborntoamotherreceivingtamoxifen AT yayoimiyazono afollowupreportofaninfantborntoamotherreceivingtamoxifen AT hidetoshitakada afollowupreportofaninfantborntoamotherreceivingtamoxifen AT yukiokada followupreportofaninfantborntoamotherreceivingtamoxifen AT daisukehitaka followupreportofaninfantborntoamotherreceivingtamoxifen AT takahirokido followupreportofaninfantborntoamotherreceivingtamoxifen AT yukanai followupreportofaninfantborntoamotherreceivingtamoxifen AT kumikonishi followupreportofaninfantborntoamotherreceivingtamoxifen AT kosukedoki followupreportofaninfantborntoamotherreceivingtamoxifen AT nobukokatayama followupreportofaninfantborntoamotherreceivingtamoxifen AT masatohomma followupreportofaninfantborntoamotherreceivingtamoxifen AT yayoimiyazono followupreportofaninfantborntoamotherreceivingtamoxifen AT hidetoshitakada followupreportofaninfantborntoamotherreceivingtamoxifen |